Lexeo Therapeutics Announces In-License Agreement With Cornell University To Expedite Development Of LX2006 For Treatment Of Friedreich Ataxia Cardiomyopathy; Under Agreement, Co. Has Acquired Certain Rights1 Including Rights To Current And Future Data Generated In An Ongoing Investigator-initiated Phase 1A Trial Of AAVrh.10hFXN To Treat Fa Cardiomyopathy
Lexeo Therapeutics宣布与康奈尔大学签订许可协议，以加快开发用于治疗弗里德雷希共济失调心肌病的 LX2006；根据协议，Co.已获得某些权利1 包括研究人员发起的用于治疗 Fa 心肌病的 Aavrh.10HFXN 1A 期临床试验中生成的当前和未来数据的权利